Resumo

CORREA-GONZALEZ, Lourdes Cecilia et al. Prognostic value of pre-B immunophenotype in early treatment response among acute pediatric lymphoblast leukemia patients. Gac. Méd. Méx [online]. 2005, vol.141, n.6, pp.477-482. ISSN 2696-1288.

Objective: To determine the prognostic value of pre B immunophenotype and its variants on early treatment response among of acute pediatric lymphoblast leukemia. Patients and methods: A case control study nested in a cohort was carried out with male and female patients 15 years and younger with recently diagnosed pre B lymphoblast leukemia. A panel of B, T, monoclonal antibodies of the myelo monocytic and megakaryocytic cell type was used. Response was assessed by bone marrow aspiration 14 days post treatment. Results: 54 patients were included. The median age was 7 years (2 months - 14 years) median leukocyte count was 13,450/mm3 (1200-986,000/mm3). We identified 29 cases with late pre B immune phenotype, 19 cases with common pre B and 6 cases with early pre B immunophenotype. Eleven patients also displayed myeloid antigens. A significant association (p=0.034) was found between early treatment response and the presence of myeloid antigens. No association was found between the pre B immunophenotype, age and leukocyte count with early treatment response (p=0.264). Conclusions: We need to pay special emphasis on early treatment response in children with lymphoblast leukemia as our study did not corroborate the common finding that clinical factors and immune phenotype can be predictive factors.

Palavras-chave : Acute lymphoblast leukemia; immunophenotype; early response; prognostic factor.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )